Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL)
Clinical trial NCT04611880 · COMPLETED
Trial details
- NCT number
- NCT04611880
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-25
- Primary completion
- 2025-04-02
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.